+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tumor Marker"

The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition - Product Thumbnail Image

The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition

  • Report
  • August 2023
  • 1500 Pages
  • Global
From
In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022 - Product Thumbnail Image

In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022

  • Report
  • October 2022
  • 348 Pages
  • Singapore, Malaysia, Indonesia Singapore, Malaysia, Indonesia
From
United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition - Product Thumbnail Image

United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition

  • Report
  • October 2022
  • 220 Pages
  • United States
From
In Vitro Diagnostics (IVD) in India - Product Thumbnail Image

In Vitro Diagnostics (IVD) in India

  • Report
  • June 2022
  • 55 Pages
  • India
From
The Market for In Vitro Diagnostic Tests in Latin America - Product Thumbnail Image

The Market for In Vitro Diagnostic Tests in Latin America

  • Report
  • June 2021
  • 197 Pages
  • Latin America
From
The IVD Market in South Korea, 2024 - Product Thumbnail Image

The IVD Market in South Korea, 2024

  • Report
  • February 2024
  • 72 Pages
  • South Korea
From
IVD Procedure Volumes 2021-2026 - Product Thumbnail Image

IVD Procedure Volumes 2021-2026

  • Report
  • March 2022
  • 312 Pages
  • Global
From
In Vitro Diagnostics (IVD) Market in China, 2021 - Product Thumbnail Image

In Vitro Diagnostics (IVD) Market in China, 2021

  • Report
  • September 2021
  • 144 Pages
  • China
From
From
From
From
From
Loading Indicator

The Tumor Marker market is a segment of the In Vitro Diagnostics (IVD) industry. It is composed of products used to detect the presence of cancer in a patient. These products are typically used to diagnose, monitor, and assess the effectiveness of cancer treatments. Tumor markers are typically proteins, hormones, or other substances that are produced by cancer cells or by the body in response to cancer. They can be detected in the blood, urine, or other body fluids. The Tumor Marker market is a rapidly growing segment of the IVD industry, driven by the increasing prevalence of cancer and the need for early diagnosis and effective treatment. The market is expected to continue to grow in the coming years, driven by technological advancements and the development of new products. Some of the major companies in the Tumor Marker market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more